BioSpace News Archive

Sorrel Medical (sorrelmedical.com), a developer and manufacturer of wearable drug delivery devices, today announced the appointment of Bentsi Algazi as Vice President of Operations to meet growing interest in its award-winning wearable self-injection devices.

TARRYTOWN, N.Y. , Feb. 4, 2020 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) today announced an expanded agreement with the U.S. Department of Health and Human Services (HHS) to develop new treatments combating the novel coronavirus, 2019-nCoV, which was recently declared a global public health emergency by the World Health Organization.

HAYWARD, Calif. , Feb. 4, 2020 /PRNewswire/ -- Potrero Medical announced today that Jeff Mack is joining its executive leadership team as its Chief Financial Officer (CFO) and will report to CEO Joe Urban . Jeff brings more than 30 years of finance and capital markets experience to Potrero Medical.

One Call, the nation’s leading provider of specialized healthcare solutions for the workers’ compensation industry, announced that Thomas Warsop has been appointed Chief Executive Officer.

AIROS® Medical, Inc., a medical technology manufacturer specializing in compression therapy devices that treat cancer-related lymphedema as well as venous disorders, today announced it has received trademark registration from the United States Patent and Trademark Office (USPTO) for its company and brand name, “AIROS”.

Article 223-16 of general regulation of French Autorité des Marchés Financiers

RenalTech predicts chronic kidney disease in cats two years before it occurs; receives top honors

Jupiter Medical Center is pleased to announce that it has received a 4-star rating for Overall Hospital Quality from the Centers for Medicare & Medicaid Services.

Investis Digital, a leading global digital communications company, announced the launch of a new practice that will help healthcare companies accelerate the pace of clinical development by improving the way they recruit patients for clinical trials.

Qualigen, Inc., a privately-owned company focused on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases, as well as expansion of its flagship FastPack® diagnostic platform, announced today the issuance of U.S. Patent Number D865210, which covers advanced design aspects of Qualigen’s FastPack technology.